Top

Published in:

Open Access 01-08-2020 | Overactive Bladder | Special Contribution

Vaginal laser for overactive bladder syndrome

Authors: Ioannis Charalampous, Visha K. Tailor, Alex Digesu

Published in: International Urogynecology Journal | Issue 8/2020

Abstract

Overactive bladder syndrome (OAB) is defined as urinary urgency, usually with urinary frequency and nocturia, with or without urge urinary incontinence. The prevalence of OAB in adult women ranges between 11% and 42%, is particularly common in elderly people, and can overlap with the genitourinary syndrome of menopause (GSM). There is a wide approach to the treatment of symptoms, often in a stepwise fashion, including lifestyle changes, bladder retraining and pelvic floor muscle rehabilitation, drug therapy, intra-vesical botulinum toxin injections or neuromodulation. Recently, vaginal laser therapy has been proposed as an emerging minimal invasive effective treatment option for women with OAB. We explore this further.

Hsu FC, Weeks CE, Selph SS, Blazina I, Holmes RS, McDonagh MS. Updating the evidence on drugs to treat overactive bladder: a systematic review. Int Urogynecol J. 2019;30(10):1603–17. https://doi.org/10.1007/s00192-019-04022-8.CrossRefPubMedPubMedCentral

Bhide AA, Khullar V, Swift S, Digesu GA. The use of laser in urogynaecology. Int Urogynecol J. 2019;30(5):683–92. https://doi.org/10.1007/s00192-018-3844-7.CrossRefPubMed

Shobeiri SA, Kerkhof MH, Minassian VA, Bazi T. IUGA Research and Development Committee. IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Int Urogynecol J. 2019;30(3):371–6. https://doi.org/10.1007/s00192-018-3830-0.CrossRefPubMed

Tranoulis A, Georgiou D, Michala L. Laser treatment for the management of genitourinary syndrome of menopause after breast cancer. Hope or hype? Int Urogynecol J. 2019;30(11):1879–86. https://doi.org/10.1007/s00192-019-04051-3.CrossRefPubMed

Garcia B, Pardo J. Academic cosmetic gynecology and energy-based therapies: ambiguities, explorations, and FDA advisories. Int Urogynecol J. 2019;30(1):1–2. https://doi.org/10.1007/s00192-018-3812-2.CrossRefPubMed

Dabaja H, Lauterbach R, Matanes E, Gruenwald I, Lowenstein L. The safety and efficacy of CO₂ laser in the treatment of stress urinary incontinence. Int Urogynecol J 2019;30(10):1603–17. https://doi.org/10.1007/s00192-019-04204-4.CrossRef

Kuszka A, Gamper M, Walser C, Kociszewski J, Viereck V. Erbium:YAG laser treatment of female stress urinary incontinence: midterm data. Int Urogynecol J 2019. https://doi.org/10.1007/s00192-019-04148-9.CrossRefPubMed

González Isaza P, Jaguszewska K, Cardona JL, Lukaszuk M. Long-term effect of thermoablative fractional CO₂ laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause. Int Urogynecol J. 2018;29(2):211–5. https://doi.org/10.1007/s00192-017-3352-1.CrossRefPubMed

Perino A, Cucinella G, Gugliotta G, Saitta S, Polito S, Adile B, et al. Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? Preliminary results. Eur Rev Med Pharmacol Sci. 2016;20(12):2491–7.PubMed

10.

Aguiar LB, Politano CA, Costa-Paiva L, Juliato CRT. Efficacy of fractional CO₂ laser, Promestriene, and vaginal lubricant in the treatment of urinary symptoms in postmenopausal women: a randomized clinical trial. Lasers Surg Med 2020. https://doi.org/10.1002/lsm.23220.CrossRefPubMed

11.

Lin YH, Hsieh WC, Huang L, Liang CC. Effect of non-laser treatment on overactive bladder symptoms, urinary incontinence and sexual function in women with urodynamic stress incontinence. Taiwan J Obstet Gynecol. 2017;56(6):815–20. https://doi.org/10.1016/j.tjog.2017.10.020.CrossRefPubMed

12.

Okui N. Efficacy and safety of non-ablative vaginal erbium: YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and β3-adrenoceptor agonists. World J Urol. 2019;37(11):2459–66. https://doi.org/10.1007/s00345-019-02644-7.CrossRefPubMedPubMedCentral

Title: Vaginal laser for overactive bladder syndrome
Authors: Ioannis Charalampous
Visha K. Tailor
Alex Digesu
Publication date: 01-08-2020
Publisher: Springer International Publishing
Keywords: Overactive Bladder
Urinary Incontinence
Nerve Stimulation
Botulinum Toxin
Urinary Incontinence
Genitourinary Syndrome of Menopause
Laser
Published in: International Urogynecology Journal / Issue 8/2020
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-020-04319-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Vaginal laser for overactive bladder syndrome

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2020

The safety and efficacy of CO2 laser in the treatment of stress urinary incontinence

Abstracts Presented at the Annual Research meeting of the British Society of Urogynaecology (BSUG), London. October 2019

Letter to the editor: Impact of postoperative instructions on physical activity following pelvic reconstructive surgery: a randomized controlled trial

Letter to the editor: selective episiotomy versus no episiotomy for severe perineal trauma: a systematic review with meta-analysis

Provider miscategorization of frailty in an outpatient urogynecologic population

Appropriateness of referrals to a urogynecology practice